Global Drug Bioavailability Enhancement Summit 2022: Two Day Online Program – May 16-17, 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2022 Global Drug Bioavailability Enhancement Summit” conference has been added to ResearchAndMarkets.com’s offering.

Are you tasked with improving drug performance, bioavailability, and patient adherence? Would you like to uncover new strategies to reduce dosage, cost and decrease time-to-market on products?

Check out the 2022 Global Drug Bioavailability Enhancement Summit program agenda and walk away with over 2 years of novel drug formulation and bioavailability enhancement approaches strategies. Learn directly from 30+ senior drug bioavailability pioneers and network with 120+ senior drug development innovators this coming May in Philadelphia, PA.

2022’s 2-Day program showcases the industry’s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. 2022’s Summit will share cutting-edge research on the development, characterization, and manufacture of formulations that span multiple modalities.

• Precision medicine & healthcare delivery
• Rationale formulation design for poorly soluble compounds
• In-vivo – in-vitro correlation
• Solution behavior of amorphous solid dispersions
• Nanosuspension for improving the bioavailability
• Early formulation screening in drug discovery
• 3D printing for biopharmaceuticals
• Enhancing patient adherence via drug delivery
• Innovative strategies around drug/device combinations

2021’s Speakers Included:

Manish Gupta, PhD

Senior Director, Pharmaceutical Development – Sterile

GlaxoSmithKline

Dedong Wu, PhD

Senior Scientist, Solid State

AstraZeneca

Arijit Chakravarty, PhD

Chief Executive Officer

Fractal Therapeutics

Rick Panicucci, PhD

Senior Vice President, CMC

QED Therapeutics

Saji Vijayan, PhD

Vice President- R&D Strategy

Endo Pharmaceuticals

Sune Anderson, PhD

Principal Scientist, Spray Drying

Johnson & Johnson

Susan Rosenbaum

Founder, Chairman & Chief Executive Officer

Lauren Sciences

Stephen Tindal, PhD

Director, Science & Technology

Catalent Pharma Solutions

Melanie Marota, PhD

Associate Principal Scientist, Pharmaceutical Sciences

Merck & Co.

Eric Munson, PhD

Patrick DeLuca Endowed Professor in Pharmaceutical Technology, Department of Pharmaceutical Sciences

Purdue University

Di Wu, PhD

Senior Scientist, Formulation Development

Merck & Co.

Stephen Stern, PhD

Director of Research and Development, Head of the Pharmacology and Toxicology Section

Nanotechnology Characterization Laboratory

Dabing Chen, PhD

Senior Principal Scientist

Boehringer Ingelheim

Xin Liu, PhD

Associate Director of Pharmaceutical Product Development

Triasek

Christoph Nuboldt

Senior Researcher

INVITE GmbH

Sudhakar Garad, PhD

Global Head of Chemical and Pharmaceutical Profiling

Novartis

For more information about this conference visit https://www.researchandmarkets.com/r/3f8fft

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900